While clinical research and trials have globalized, the frameworks governing it – specifically Responsible Research and Innovation (RRI) – remain predominantly Western-centric. This special issue aims to provide a critical platform for exploring and advancing the lifecycle of clinical research and trials through the lens of responsible research and innovation (RRI) and from the global majority context. Authors are invited to submit full-length original research articles, case studies, policy perspectives, and critical reviews to the special issue. By contributing your work, we’re collectively growing a body of literature that advocates for equity in global healthcare by strengthening global infrastructures and local capabilities to ensure that research and practice truly serve the evolving realities of the Global Majority.
Key areas of inquiry could include these sub-topics:
Responsive and Adaptive Governance of DHT
Capacity Building and Infrastructure Issues
Public Engagement and Deliberation
Data Ethics and Governance
Artificial Intelligence used in Clinical Trials
Trustworthy Innovations for Clinical Trials, Research and/or Practice
Submitting authors are strongly encouraged to review for the special issue. Article Publishing Charge applies for all articles accepted in this special issue.
Submission deadline: 30 November 2026